Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 1692-1697, June 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeWys, W. D.
Right arrow Articles by Mantel, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeWys, W. D.
Right arrow Articles by Mantel, N.

Hematopoietic Recovery after Large Doses of Cyclophosphamide: Correlation of Proliferative State with Sensitivity1

William D. DeWys2, Abraham Goldin and Nathan Mantel

Cancer Chemotherapy National Service Center [W. D. DeW., A. G.], and Biometry Branch, [N. M.], National Cancer Institute, Bethesda, Maryland 20014

Hematological recovery after a large dose of cyclophosphamide was characterized by early rapid recovery of marrow stem cells (colony-forming assay), followed successively by recovery of circulating stem cells (colony-forming assay), total marrow cellularity, and circulating blood cells. This recovery sequence provided a model in which marrow with different proliferative rates could be studied for sensitivity to cyclophosphamide by subjecting animals to a second treatment at various intervals after an initial treatment. The results of this type of study suggest that the proliferative state of a cell population is a determinant of sensitivity to cyclophosphamide.

1 This study was supported in part by Contract PH 43-64-91 from the Cancer Chemotherapy National Service Center. A preliminary report has been presented (10).

2 To whom reprint requests should be sent at the Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, N. Y. 14620.

Received 11/10/69. Accepted 2/ 3/70.




This article has been cited by other articles:


Home page
BloodHome page
K. Kusano, S. Ebara, K. Tachibana, T. Nishimura, S. Sato, T. Kuwaki, and T. Taniyama
A potential therapeutic role for small nonpeptidyl compounds that mimic human granulocyte colony-stimulating factor
Blood, February 1, 2004; 103(3): 836 - 842.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.